[Federal Register: March 18, 2003 (Volume 68, Number 52)]
[Notices]
[Page 12913]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18mr03-62]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Science Board to the Food and Drug Administration; Notice of
Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Science Board to the Food and Drug
Administration.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on April 9, 2003, from 8
a.m. to 4:30 p.m.
Location: Food and Drug Administration, rm. 1066, 5630 Fishers
Lane, Rockville, MD 20857.
Contact Person: Susan Bond, Office of the Commissioner, Food and
Drug Administration (HF-33), 5600 Fishers Lane, Rockville, MD 20857,
301-827-6687, sbond@oc.fda.gov, or FDA Advisory Committee Information
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code
12603. Please call the Information Line for up-to-date information on
this meeting.
Agenda: The board will hear and discuss the FDA's launched
initiative to improve the development and availability of innovative
medical products, specifically in the area of pharmacogenomics. The
board will also hear updates on the pharmaceutical manufacturing
initiative.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by March 28,
2003. Oral presentations from the public will be scheduled between
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may
be limited. Those desiring to make formal oral presentations should
notify the contact person before March 28, 2003, and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their
presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Susan Bond at least
7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: March 10, 2003.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 03-6367 Filed 3-17-03; 8:45 am]
BILLING CODE 4160-01-S